Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,537 | 29,332 | 17,021 | 24,561 | 80,011 |
| Receivables | 171,656 | 177,953 | 157,594 | 160,208 | 158,312 |
| Inventories | 58,119 | 53,214 | 52,536 | 42,508 | 38,493 |
| Other current assets | 0 | 12,029 | 0 | 0 | 0 |
| TOTAL | $284,326 | $286,548 | $254,423 | $254,691 | $304,719 |
| Non-Current Assets | |||||
| PPE Net | 114,812 | 115,295 | 110,025 | 105,126 | 103,061 |
| Intangibles | 170,863 | 171,008 | 170,295 | 162,419 | 162,616 |
| Other Non-Current Assets | 40,677 | 38,022 | 28,158 | 29,997 | 26,878 |
| TOTAL | $326,352 | $324,325 | $308,478 | $297,542 | $292,555 |
| Total Assets | $610,678 | $610,873 | $562,901 | $552,233 | $597,274 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,487 | N/A | 84,493 | 89,747 | 105,316 |
| Accounts payable and accrued liabilities | 48,189 | 57,639 | 46,776 | 61,331 | 48,749 |
| Accrued Expenses | 24,754 | 34,028 | 30,470 | 28,087 | 25,949 |
| TOTAL | $131,673 | $143,195 | $210,119 | $236,098 | $252,511 |
| Non-Current Liabilities | |||||
| Long Term Debt | 198,066 | 223,075 | 155,602 | 2,183 | 4,523 |
| Deferred Revenues | 25,757 | 19,154 | 18,912 | 22,830 | 28,855 |
| Other Non-Current Liabilities | 62,162 | 57,334 | 58,888 | 61,817 | 57,522 |
| TOTAL | $264,741 | $286,023 | $214,732 | $63,933 | $61,747 |
| Total Liabilities | $396,414 | $429,218 | $424,851 | $300,031 | $314,258 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,486 | 47,621 | 46,627 | 46,585 | 45,613 |
| Common Shares | 1,376 | 1,262 | 1,376 | 1,397 | 1,397 |
| Retained earnings | 324,277 | 283,660 | 296,172 | 459,634 | 546,372 |
| Other shareholders' equity | 2,022 | 1,607 | -2,498 | -2,829 | -3,753 |
| TOTAL | $214,264 | $181,655 | $138,050 | $252,202 | $283,016 |
| Total Liabilities And Equity | $610,678 | $610,873 | $562,901 | $552,233 | $597,274 |